GlassScriptPhysician profile
Patrick N Farr
NPI 1982792776
$1,610.85
in general payments reported to CMS, 2019-2025
16 companies · $279 in 2025
The $279 reported for 2025 was more than what 83% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $266 · 2020: $293 · 2021: $88.03 · 2022: $156 · 2023: $236 · 2024: $293 · 2025: $279.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $808.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $808.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $318.88 | 2022-2025 | Azstarys |
| Glaxosmithkline, LLC. | $286.82 | 2019-2025 | Bexsero, Pediarix, Penmenvy |
| Pfizer INC. | $217.30 | 2022-2025 | |
| Welch Allyn | $162.28 | 2020 | |
| Ironshore Pharmaceuticals INC. | $151.47 | 2019-2023 | Jornay Pm |
| Merck Sharp & Dohme LLC | $95.16 | 2019-2025 | Vaxneuvance, Gardasil 9, Vaxelis |
| Supernus Pharmaceuticals, INC. | $87.90 | 2024-2025 | Qelbree |
| Teva Pharmaceuticals USA, INC. | $74.96 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $43.60 | 2020 | |
| Sobi, INC | $42.95 | 2019-2020 | |
| Tris Pharma INC | $35.75 | 2020-2021 | |
| Seqirus USA INC | $33.88 | 2022-2025 | Flucelvax |
| Arbor Pharmaceuticals, INC. | $16.17 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $15.61 | 2024 | Zoryve |
| Astrazeneca Pharmaceuticals LP | $15.51 | 2023 | Flumist Quadrivalent |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $12.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Farr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.